| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,194 |
3,076 |
$307K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,511 |
4,341 |
$297K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
988 |
967 |
$96K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
736 |
730 |
$74K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
520 |
518 |
$50K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
729 |
706 |
$40K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
224 |
218 |
$22K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
218 |
214 |
$19K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
298 |
287 |
$9K |
| 90686 |
|
747 |
747 |
$6K |
| 90723 |
|
132 |
132 |
$5K |
| 90670 |
|
411 |
407 |
$3K |
| 99383 |
|
16 |
16 |
$2K |
| 90647 |
|
185 |
183 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30 |
29 |
$1K |
| 90677 |
|
117 |
117 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
24 |
22 |
$994.38 |
| 90633 |
|
64 |
64 |
$501.70 |
| 90734 |
|
44 |
43 |
$401.06 |
| 90651 |
|
38 |
38 |
$309.07 |
| 87807 |
|
14 |
14 |
$176.55 |
| 91307 |
|
17 |
16 |
$0.00 |